Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoVitTrial: High-Dose vs Standard-Dose Vitamin D3 in High-Risk COVID-19
NCT04344041Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Apr 2020
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of vitamin d in coronavirus disease 2019 (COVID-19), sponsored by Centre Hospitalier Universitaire d'Angers. Started Apr 2020; status: completed.
02
Drugs
vitamin d
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04344041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04344041.